Zobrazeno 1 - 10
of 34
pro vyhledávání: '"John Tesser"'
Autor:
Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Ruizhi Sophia Zhao, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 304-311 (2024)
Objective Evaluate patient‐reported outcomes after 6 months of on‐label guselkumab use in patients with rheumatologist‐diagnosed active psoriatic arthritis (PsA) enrolled in the CorEvitas PsA/Spondyloarthritis Registry. Methods This analysis in
Externí odkaz:
https://doaj.org/article/197c05cdb19f4b9fb26fe2baaf5f58b3
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background This study sought to evaluate the efficacy and safety of tofacitinib in patients with rheumatoid arthritis with distinct treatment histories. Methods Pooled phase II/III trial data from patients who received tofacitinib 5 or 10 mg
Externí odkaz:
https://doaj.org/article/7911c65fbf6142c1825230c24b2584dd
Autor:
Philip J. Mease, Alexis Ogdie, John Tesser, Natalie J. Shiff, Iris Lin, Soumya D. Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R. McLean, Aaron Broadwell, Arthur Kavanaugh, Joseph F. Merola
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1479-1501 (2023)
Abstract Introduction The aim of this work is to evaluate treatment persistence and clinical outcomes after 6 months of on-label guselkumab use in patients with rheumatologist-diagnosed active psoriatic arthritis (PsA) enrolled in the CorEvitas PsA/S
Externí odkaz:
https://doaj.org/article/670a15e0810945e28ecb889c8800099e
Autor:
Joseph F Merola, Atul Deodhar, Philip J Mease, Shihong Sheng, Iain B McInnes, Soumya D Chakravarty, Elena Schiopu, Yanli Wang, Wolf-Henning Boehncke, Christopher T Ritchlin, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, May Shawi, Stephen Xu, John Tesser
Publikováno v:
RMD Open, Vol 8, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/6e550c0266f941509759d9b9b5b88af6
Autor:
John Tesser, Shelly Kafka, Raphael J. DeHoratius, Stephen Xu, Elizabeth C. Hsia, Anthony Turkiewicz
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-9 (2019)
Abstract Objective To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged
Externí odkaz:
https://doaj.org/article/5fcf4bf9f6e94dd3964baebe663bd90d
Autor:
John Tesser, Iris Lin, Natalie J. Shiff, Soumya D. Chakravarty, Gabriela Schmajuk, Nevin Hammam, Sheetal Desai
Publikováno v:
Clinical rheumatology, vol 41, iss 8
Infliximab and golimumab are intravenously (IV) administered tumor necrosis factor inhibitors approved to treat moderate-to-severe rheumatoid arthritis (RA) with concomitant methotrexate. Owing to differences in biologic construct, patients with IV-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::540898510b70a58a808b287d6e6a84a4
https://escholarship.org/uc/item/6f01d0gh
https://escholarship.org/uc/item/6f01d0gh
Autor:
Jeffrey L. Kaine, Liza Takiya, Ryan DeMasi, Vara Bandi, Jürgen Wollenhaupt, Haiyun Fan, M. Snyder, Koshika Soma, John Tesser, Lisy Wang
Publikováno v:
Clinical Rheumatology
Introduction/objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). This post-hoc analysis evaluated the effect of temporary discontinuation and reinitiation of tofacitinib on disease control in patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863c7061a85c30ce5bc635c6a91805f6
https://doi.org/10.1007/s10067-020-04956-1
https://doi.org/10.1007/s10067-020-04956-1
Autor:
Christopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, John Tesser, Elena Schiopu, Soumya D Chakravarty, Alexa P Kollmeier, Xie L Xu, May Shawi, Yusang Jiang, Shihong Sheng, Yanli Wang, Stephen Xu, Joseph F Merola, Iain B McInnes, Atul Deodhar
ObjectivesTo evaluate the efficacy through 52 weeks of guselkumab, an interleukin 23-p19 subunit inhibitor, in subgroups of pooled psoriatic arthritis (PsA) patients from the DISCOVER-1 and DISCOVER-2 trials defined by baseline patient characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1430cfcaf053af474652e43069b69b8
https://eprints.gla.ac.uk/267411/1/267411.pdf
https://eprints.gla.ac.uk/267411/1/267411.pdf
Autor:
Michael E. Weinblatt, Howard M. Kenney, Lin Zhao, Brian LaMoreaux, John K. Botson, Ralph Bennett, Yang Song, Yan Xin, Jeff Peterson, Katie Obermeyer, Srini Ramanathan, Paul M. Peloso, John Tesser, Jason Chamberlain
Background: Publications suggest immunomodulation co-therapy improves responder rates in uncontrolled/refractory gout patients undergoing pegloticase treatment. The MIRROR open-label trial showed a 6-month pegloticase+methotrexate co-therapy responde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e8d628a0ca4577fe49d6b4a9a7d19e6
https://doi.org/10.21203/rs.3.rs-951365/v1
https://doi.org/10.21203/rs.3.rs-951365/v1
Autor:
Anthony Turkiewicz, Elizabeth C. Hsia, Raphael J. DeHoratius, Stephen Xu, John Tesser, S. Kafka
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-9 (2019)
Arthritis Research & Therapy
Arthritis Research & Therapy
Objective To evaluate the safety and efficacy of intravenous golimumab + methotrexate (MTX) in patients with active rheumatoid arthritis (RA) aged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29a1cc5efe7d9c298041a58c00e2e66
http://link.springer.com/article/10.1186/s13075-019-1968-x
http://link.springer.com/article/10.1186/s13075-019-1968-x